SCHEMBL31387302

SCHEMBL31387302

CC1CC2(CCN1C(=O)OC(C)(C)C)OCCc1cc(CC(F)F)sc12

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 20/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26059141 1.00 OPRL1 (0.36) OPRL1
SCHEMBL31387422 0.89 JAK2 (0.36) OPRL1
SCHEMBL26066260 0.89 JAK2 (0.36) OPRL1
SCHEMBL26066409 0.89 JAK2 (0.36) OPRL1
SCHEMBL31387369 0.89 JAK2 (0.36) OPRL1
SCHEMBL25357190 0.88 OPRL1 (0.40) OPRL1
SCHEMBL25355295 0.88 OPRL1 (0.40) OPRL1
SCHEMBL30623268 0.88 JAK2 (0.35) OPRL1
SCHEMBL31387456 0.88 JAK2 (0.35) OPRL1
SCHEMBL26066279 0.88 JAK2 (0.35) OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119343353-A 2-Methyl-4 ',5' -dihydrospiro [ piperidine-4, 7' -thieno [2,3-c ] pyran ] derivatives as APOL1 inhibitors and methods of use thereof 弗特克斯药品有限公司 2025-01-21 CN disclosed